SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-125156
Filing Date
2019-04-29
Accepted
2019-04-29 16:07:55
Documents
3
Period of Report
2019-04-29
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d734509d8k.htm 8-K 16509
2 EX-99.1 d734509dex991.htm EX-99.1 10575
3 GRAPHIC g734509g91b47.jpg GRAPHIC 5464
  Complete submission text file 0001193125-19-125156.txt   35837
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38096 | Film No.: 19775928
SIC: 2834 Pharmaceutical Preparations